Elise F. Nassif, MD

Assistant Professor
University of Texas MD Anderson Cancer Center

I am a physician-scientist in the Department of Sarcoma Medical Oncology. I have a particular interest in the care of patients with leiomyosarcomas and undifferentiated pleomorphic sarcomas. During my residency and fellowship in France, I trained at Gustave Roussy Cancer Center and completed a master of science in Immunology in 2019. After completion of my clinical training, I pursued a research post-doctoral fellowship at MD Anderson during two years, focusing on characterizing the immune microenvironment of sarcomas and identifying new immune therapeutic targets to improve sarcoma care. My main research focus are leiomyosarcomas, undifferentiated pleomorphic sarcomas, immunotherapy, and drug development in sarcomas.

Poster(s):

• (P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA

• (P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)

• (P 123) DEDIFFERENTIATED LIPOSARCOMAS TREATED WITH IMMUNE CHECKPOINT BLOCKADE: THE MD ANDERSON EXPERIENCE

• (P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE